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CHAPTER ONE
INTRODUCTION
The two leading causes of increased morbidity and mortality after burn injury are
sepsis and multiple organ dysfunction syndrome (MODs). Over 75% of all burn related
deaths occur as a result of sepsis or infectious complications1. Immediately following
injury patients experience a systemic inflammatory response, which presents as a surge of
pro-inflammatory cytokine release2. This shift toward a pro-inflammatory environment
from one of a healthy balance of pro- and anti-inflammatory cytokines manifests not only
at the site of burn injury, but in extraneous sites of the lung, liver, and intestinal tract 3.
Coupled with the suppression of the immune system seen after serious burn injury, this
inflammation increases patient susceptibility to sepsis and subsequent multiple organ
failure2-4. Intestinal bacteria are the main source of bacterial infection following burn
injury3,5-7.
The intestinal tract contains over 100 trillion microbes, and under normal
conditions maintains a symbiotic relationship benefiting the host by aiding in metabolism
and nutrients, protection from invading pathogens, and immune system development and
function8-11. In a healthy individual, intestinal epithelial cells maintain a physiological
and immunological barrier sequestering both commensal and pathogenic bacteria to the
luminal space9,12,13. After burn trauma intestinal epithelial cells undergo intense cellular

1

stress, which contributes to the barrier breakdown following injury

14,15

2
. This

perturbation in gut barrier integrity could result in bacterial translocation out of the
luminal space into extraintestinal sites ending in SIRS, sepsis, and multiple organ
dysfunction3-5,7,14-16.

However, the exact mechanism of gut barrier breakdown and

subsequent burn related pathophysiologies remain largely unknown.
The intestinal barrier can be understood as both an immune barrier and a physical
barrier. With T and B cells, macrophages, and dendritic cells of the Payer’s patches (PP),
mesenteric lymph nodes (MLN), and lamina propria (LP) of the gut associated lymphoid
tissue (GALT) making up the intestinal immune barrier, and then tight junctional
complexes, adherens junctions, and desmosomes between intestinal epithelial cells
(IECs), contributing to the physical intestinal barrier.

In particular tight junctional

complexes of the small and large intestine are made up of the proteins: claudin, occludin,
and zonal-occludin. These proteins are imperative to the maintenance of the physical
intestinal barrier prohibiting translocation of bacteria out of the lumen while allowing the
selective absorption of critical nutrients required by the host. Tight junctional complexes
are not limited to the make-up of intestinal barrier, but exist in many other natural
barriers of the body such as the lungs, kidney, and blood brain barrier, etc. Many studies
on tight junction proteins at other barrier sites have implicated the role of heat shock
proteins (HSPs) as support for tight junction protein integrity.
HSPs are classified as small cytoprotective proteins, which are induced after
stresses such as heat, cytotoxic drugs, and bacterial endotoxins. Cell stress is alleviated
by HSPs, which function to chaperone denatured proteins back to the endoplasmic

3
17,18

reticulum allowing for correct re-folding

. Burn injury can result in intense cellular

stresses, which can consequently lead to an accumulation of denatured proteins.
However, there exists a gap in the knowledge of the potential role HSPs could play in
upholding the integrity of tight junction proteins in intestinal epithelial cells and,
therefore, proper maintenance of the physical barrier of intestine following burn injury.
Understanding the interplay between burn related intestinal inflammation and the
consequential intestinal barrier breakdown opens the doors for novel therapies in the
treatment of burn patients. As Inflammatory Bowel Disease (IBD) mimics many of the
inflammatory symptoms seen in the intestine after burn injury, applying common
therapeutics currently used in IBD treatment and prevention, such as mesalamine, for the
treatment of burn injury could yield promising results. Mesalamine inhibits inflammation
through the inhibition of NF-κB and is theorized to upregulate the HSP response,
resulting in alleviation of stress induced inflammation19-21. Although it’s benefits in the
treatment of ulcerative colitis and Crohn’s disease have been extensively studied,
mesalamine’s potential for therapeutic intervention has yet to be applied in the context of
burn injury. The studies performed herein profile the alterations in the heat shock
response following burn trauma, which could contribute to changes tight junction
proteins and gut barrier integrity. Additionally, studies were also carried out to examine
whether treatment with mesalamine modulate HSPs and protect the barrier integrity after
bun injury.
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Hypothesis
Burn injury suppresses the heat shock protein response of intestinal epithelial
cells altering tight junction proteins, which results in increased intestinal permeability.
Specific Aim 1
Characterize the expression of HSPs in the intestine and correlate with barrier
integrity after burn injury.
Rationale
Our recent findings suggest that burn results in gut barrier disruption including
increases in intestinal permeability and bacterial translocation to the mesenteric lymph
nodes (MLNs). We now propose to study the effect of burn injury on HSP25, HSP72,
and HSP90.

These HSPs are implicated in the maintenance of gut homeostasis in

response to cellular stresses such as changes in the intestinal microbiome or microbial
products, hypoxia, and ischemia, all of which have been implicated as symptoms of burn
injury17,18,22-25. Proper response to cell stressors, such as burn injury, by HSPs is essential
due to their role in cell survival by facilitating the proper folding of denatured proteins.
Thus, changes in expression of these cyto-protective HSPs post burn injury could
adversely affect gut homeostasis resulting in barrier breakdown and increased leakiness
and bacterial translocation. Therefore, it is imperative to assess the expression of HSPs
in the intestine and correlate with barrier integrity after burn injury.

5
Specific Aim 2
Determine whether treatment with anti-inflammatory therapeutic, Mesalamine,
restores gut barrier integrity via upregulation of HSPs after burn injury.
Rationale
Mesalamine or 5-ASA is currently used as treatment for patients with
Inflammatory Bowel Disease (IBD)

11,21

.

IBD is a chronic inflammatory disease

characterized by gross elevations in pro-inflammatory cytokines and an over-active Th1
response in the intestinal tract. This pro-inflammatory environment results in severe
intestinal epithelial stress resulting in intestinal tissue damage and severe pain in patients
with the disease26. As of yet, there is no cure for IBD, but one therapeutic option is
treatment with 5-ASA.

The mechanism by which 5-ASA reduces symptoms of

inflammation in IBD patients remains a matter of debate in the scientific community, but
it is proposed to act through an inhibition of NF-B and/or inhibition in the release of
TNF-21. However, recent studies in vitro have shown 5-ASA to up-regulate the heat
shock protein response in intestinal epithelial cells in reaction to cellular stress. As burn
injury induces intense intestinal epithelial cellular stresses as a result of increased
inflammation and leakiness in the gastrointestinal tract. These downstream consequences
of burn injury can mimic intestinal epithelial cellular stresses seen in IBD 13,26-28.
Experiments in this aim will determine whether treatment with 5-ASA after burn injury
successfully up-regulates HSPs in IECs and consequently restores proper tight junctional
complex integrity and intestinal barrier function.

CHAPTER TWO
REVIEW OF LITERATURE
Burn Injury
As estimated by the American Burn Association 450,00 individuals succumb to
burn injuries every year, with approximately 4,000 of those individuals requiring
subsequent hospitalization29.

Burn injury remains a prominent medical issue to be

resolved, not only due to the sheer number of injuries each year, but also due to the fact
that burn trauma results in patients with increased risk of sepsis, progressing to septic
shock, and ending in multiple organ dysfunction5. Sepsis and multiple organ dysfunction
syndrome (MODS) continue to be the leading causes of burn related mortality30.
The spiral towards increased mortality as a result of sepsis and MODS in burn
patients begins with the onset of a global immune dysregulation31.

Immediately

following burn trauma patients suffer from an overwhelming inflammatory response.
This initial injury response phase, termed systemic inflammatory response syndrome
(SIRS), is dependent on cells of the innate immune system such as macrophages,
dendritic cells, and neutrophils producing vast amount of pro-inflammatory cytokines of
Il-1, IL-6, IL-10, and TNF4,5,31-35. Additionally, SIRS produces chemo-attractant proteins
needed for recruitment of pro-inflammatory cells 31. Conversely, the adaptive arm of the
immune system generates a compensatory anti-inflammatory response syndrome
6
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(CARS). CARS is defined by a host of immuno-suppressive actions. The disruption to
the normally tightly controlled immune homeostasis after burn injury ultimately increases
the patient’s susceptibility to whole body bacterial infection31. The source of infection
can be a consequence of externally acquired pathogens, or through internal commensal
bacteria acquiring pathogenicity as a result of changes in their microenvironment post
burn injury. However, it is hypothesized that the source of post burn infection is the
gastrointestinal tract36.
Burn Injury and Gut Barrier Maintenance
The lumen of the gastrointestinal tract is the major reservoir of bacteria in the
human body harboring upwards of 100 trillion organisms10.

This highlights the

importance of the integrity of the gut barrier, which functions to sequester those high
numbers of bacteria to the intraluminal space preventing bacterial translocation to
extraintestinal sites. As septic shock is a major clinical problem after burn injury, any
breakdown in gut barrier after burn trauma remains of particular interest4,5,32. Increases
in burn related pro-inflammatory cytokines and inflammatory mediators in the gut after
injury give rise to gut barrier dysfunction resulting in bacteria or bacterial endotoxins
translocation across the intestinal barrier. Translocating bacteria after burn injury have
been detected not only in the MLNs, but also in the bloodstream and other more distant
organs to the intestines including the lungs, liver, and spleen1,6,16,36. The invasion of
bacteria or their products to systemic organs post burn injury gives evidence to the
hypothesis for the gastrointestinal tract as the origin of the major burn related
complication: multiple organ dysfunction syndrome (MODS) 36.

8

Intestinal Epithelial Cell Barrier
As the largest mucosal surface in the human body, the gastrointestinal tract comes
into contact with the most dietary antigens and largest diversity of microbial organisms9.
However, it is the barrier created by the GI tract between the diverse community of
microorganisms residing in a healthy gut and extraintestinal sites that is of critical
importance. The intestinal barrier can be understood in two main parts: the immune
barrier and the physical barrier.
The immune barrier consists of cells such as dendritic cells (DCs), macrophages,
T cells, and B cells. DCs will constantly sample the intestinal lumen and present antigen
to cells of both the adaptive and innate immune system37. This, in turn, prompts the
proper immune responses of restricting commensal microbes to the lumen and effectively
eliminating potential pathogenic bacteria via secretion of cytokines by activated epithelial
cells or T cells and/or release of opsonizing antibodies such as IgA37-39.
The physical barrier of the gastrointestinal tract mainly consists of intestinal
columnar epithelial cells, which adjacently associate creating an epithelial cell lining of
the intestinal lumen. Covering the epithelial cell lining is layer of mucus secreted by
specialized epithelial cells called goblet cells40. The mucus layer prevents most bacteria
residing in the lumen of the intestine from direct contact with the epithelial cells, and
therefore, restricting improper immune responses to resident intestinal bacteria9.
Critical to the maintenance of intestinal homeostasis and the integrity of the
physical intestinal barrier are a class of proteins known as tight junction (TJ) proteins.
Even in an intact intestinal epithelial cell layer, there still exits a paracellular pathway

9

allowing for transepithelial transport between adjacent cells, but, however, needs to be
sealed against bacterial transport outside of the intestinal lumen41,42. Tight junctional
proteins create tight junctional complexes, which aid in adjacent intestinal epithelial cell
sealing. The claudins and occludins are two types of transmembrane TJ proteins, which
associate with zonal-occludin-1,2 (ZO1, ZO2) proteins.

ZO1 and ZO2 anchor the

claudins and occludins into the intestinal epithelial cells cytoskeletal component Factin43,44. Proper formation and integrity of tight junction complexes is required for a
healthy gut.
Any breakdown in gut barrier integrity, such as after injury or inflammation,
could allow for the invasion of resident bacteria into the epithelium or to extraintestinal
sites. Bacteria translocating out of the intestinal lumen can exploit their newfound
environments turning into opportunistic pathogens leading to infection and disease3,7,45.
Heat Shock Proteins (HSPs)
Heat shock proteins or HSPs are a family of highly conserved stress proteins
expressed ubiquitously across all organisms from humans to bacteria to yeast17,24,25,46-50.
First discovered in 1962, HSPs are characterized by and subsequently named by their
molecular weights, which range from approximately 15 to 110 kDa47,51. The distribution
of HSPs in different cellular compartments is widespread as it includes the cytoplasm,
endoplasmic reticulum, and nucleus52. Yet, the precise mechanistic function of HSPs has
yet to be determined, but it is well known they are essential for survival at normal or
elevated temperatures and in response to ischemia, cytokines, and energy depletion38-42.
Although exact mechanisms are still not understood, researchers have determined that
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HSPs have strong cytoprotective effects, are critical to many regulatory pathways, and
act as molecular chaperones for other proteins23,24,46,47,50,53,54.
Three of the most extensively studied HSPs are HSP72, HSP25, and HSP90, or
HSP70, 27, and 90 in humans respectively. HSP70 has at least two regulatory sequences
that interact with the major heat shock protein transcription factor, HSF1. The two
sequences of HSP70, HSPA1A and HSPA1B, will code for almost identical amino acid
sequences generating nearly indistinguishable proteins, which results in some
redundancy55,56. In particular, HSP72 was shown to be the most temperature sensitive
and highly conserved out of all the HSPs. In contrast to others in the HSP family, HSP72
is highly inducible in response to a variety of stressors, such as hypoxia, ischemia with
over-expression of HSP70 protecting from ischemic heart injury by enhancing postischemic contractile function57 , reactive oxygen species, and pro-inflammatory cytokines
like TNF-.
Unlike the ATP-dependent HSP72, HSP25 acts completely independently of
ATP, as do many of the other small molecular weight HSPs.

Mammalian HSP25

proteins have the ability to dimerize under conditions of stress. It theorized that a unique
cysteine residue on HSP25 gives it its ability to act as an anti-apoptotic protein under
threats of apoptosis due to injury58,59. Lastly, HSP90 comprises approximately 1-2% of
all cellular proteins in a cell, as it is so ubiquitously expressed. Like HSP25, HSP90
requires dimerization to properly function, but it differs in its dependency on ATP,
similar to that of HSP72. Unique to HSP90 is its ability to bind more than one naïve or
stress-induced mis-folded protein in order to aid its proper folding/re-folding60-62.
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In the context of the gastrointestinal tract, there exists a fine-tuned relationship
between the resident microflora, intestinal epithelial cells, and HSP induction17,26,45,63-65.
It is of interest to note that HSP25 and 72 are present only at low basal amounts in the
healthy distal small intestine and large intestine66,67.

Kojima et. al found that this

distribution of HSP25 and 72 was due to the differential amounts of bacteria as one
descends down the GI tract, with greater number and diversity of bacteria from small to
large intestine66. A healthy human gut requires the presence of the resident microflora,
but under normal physiologic conditions microbial overgrowth is restricted, in part, by
innate immune responses from intestinal epithelial cells. Their study, and others, have
provided evidence for the fact that potential pathogenic bacteria or bacterial products
upregulate the HSP25 and 72 response65-68.

As both HSPs are known to be

cytoprotective, their induction would allow for intestinal epithelial cell protection of
critical cellular functions and viability. Compromised expression of either HSP25 or 72
in the small or large intestine could potentially increase susceptibility to invading
pathogens and subsequent systemic complications.
HSPs and Disease
As HSPs are renowned for their cytoprotective roles, it follows that they have
been implicated in the protection from various diseases, including Amyotrophic lateral
sclerosis (ALS), cardiovascular disease, and Inflammatory Bowel Disease (IBD). ALS is
a progressive paralysis disease characterized by the death of motoneurons in spinal cord
and motor cortex. Researchers found that treatment with a broad-spectrum inducer of
HSPs could drastically slow the progression of ALS69.
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In the context of cardiovascular disease, induction of HSPs by thermal stress
can significantly improve the outcome of ischemic heart disease. Ischemic heart disease
results in an accumulation of circulating leukocytes, leading to increased T cell and
macrophage presence in the arterial way releasing pro-inflammatory cytokines of TNF,
IL-6, and IFN-70.

As a consequence of increased inflammation, endothelial cells

undergo severe cellular stresses, which lead to tissue damage and necrosis. Currie et. al
found that hearts with HSP over-expression had improved contractile functioning in
response to ischemic conditions. Additionally, the reperfusion damage was significantly
lower than in hearts with basal levels of HSPs71.
IBD is described as a chronic inflammatory state of the gastrointestinal tract2628,72

. This pro-inflammatory state in IBD can be characterized not only by elevated

production of the pro-inflammatory cytokines TNF-, IL-6, and IL-1, but also by
elevated levels of cell adhesion molecules (CAMs) are crucial to the infiltration of
leukocytes into the bowel. Leukocyte infiltration and chronic intestinal inflammation
results in severe intestinal epithelial cell damage, which can proceed to colonic bleeding
and intense discomfort in patients26,27. However, recently, Tanaka et. al have shown that
the presence of HSPs can significantly reduce IBD symptoms of intestinal epithelial cell
damage and leukocyte infiltration compared to that of an HSF1 null mouse. However,
transgenic mice expressing the human HSP70 were found to have lower clinical scores of
IBD symptoms, less intestinal epithelial damage, and reduced levels of the proinflammatory cytokines TNF-, IL-6, and Il-1. From this they concluded that HSP70
was essential in protection from symptoms of IBD73,74.
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The above studies show strong evidence for HSPs as targets for protection from
various diseases.

Therefore, it is of upmost importance to understand how

pharmacological upregulation of HSPs could be a new, viable, therapeutic option is
disease treatment.

Mesalamine Treatment
Crohn’s disease (CD) and Ulcerative Colitis (UC) are two diseases encompassed
by the classification of IBD. While CD can affect the entirety of the gastrointestinal tract,
UC is restricted to the colon. Under normal homeostatic conditions, tolerance exists
between the resident microbes of the intestinal tract14,38-40. However, in diseases states
such as CD and UC that tolerance is broken leading to a hyper-active immune response
characterized by dramatic increases in pro-inflammatory cells such as CD8+ T cells, proinflammatory cytokines of INF-, TNF, IL-12, and IL-13, and other pro-inflammatory
chemokines75,76. No cure currently exists for patients with IBD, but several promising
treatment options are available. One such option is treatment with drug mesalamine.
Mesalamine, or 5- aminosalysylic acid (5-ASA), is presently being used as first-line
therapy for patients with either CD or UC77,78. The mechanism by which 5-ASA acts as an
anti-inflammatory agent remains a matter of debate, but it is theorized to act in several ways.
The first of which is a PPAR agonist. In other studies, PPAR agonists have been shown to
inhibit the production of the pro-inflammatory cytokines of TNF-, IL-6, and IL-1, which
are commonly elevated in IBD20,79,80. The second way in 5-ASA has been shown to act is
through the inhibition of NF-B, which would halt the transcriptional messages required for
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the increased inflammation in IBD19,20,77-79. Lastly, 5-ASA has been shown to up-regulate
HSPs, particularly HSP72, in vitro in rat intestinal epithelial cells81. Induction of HSPs in a
pro-inflammatory environment, such as after injury, could potentially assuage the detrimental
effects of the inflammation, i.e. intestinal barrier breakdown, by aiding in the re-folding of
denatured or damaged proteins as a consequence of inflammatory cell stress7,9,82.
Additionally, increases in HSPs could function to more efficiently fold naïve antiinflammatory proteins required for alleviating inflammation17,18,22,24,50,83-85

CHAPTER THREE
MATERIALS AND METHODS
Animals
Male C57BL/6 mice, 8-9 week old, weighing 22-25g, were obtained from Charles
River Laboratories are used in all experiments. Animals were allowed to acclimate to the
facility for 7-10 days before being used for the experiments. All experiments were
conducted in accordance with the guidelines set forth by the Animal Welfare Act and
were approved by the Institution Animal Care and Use Committee at the Loyola
University Chicago Health Sciences Division.
Burn Injury Procedure
Mice were anesthetized with xylazine and ketamine, their dorsal surface shaved,
and placed in a template exposing ~20% total body surface area (TBSA) as calculated by
the Meeh formula as describes by Walker and Mason86. The mice divided into two
treatment groups, those receiving burn injuries or sham injuries. The burn group was
then submerged in a water bath set to 85-95°C for 7-9 seconds while the sham group
were submerged in a water bath set to 37°C. Following burn or sham burn, all animals
were resuscitated with 1ml of normal saline. This procedure models a severe ~20%
TBSA full thickness third degree burn. The animals were sacrificed 4 hours, day 1 and
day 3 following injury. Small and large intestine were harvested and processed for the
isolation of intestinal epithelial cells for downstream experiments.
15
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Intestinal Epithelial Cell Isolation
Four hours, 1 or 3 days following the injury procedure, mice were humanley
euthanized by isoflurane asphyxiation.

Isolation of intestinal epithelial cell was

performed as described previously by Weigmann et al87. Small and large intestines were
removed from the peritoneal cavity. For small intestine ileum studies, the distal 10cm of
the small intestine was separated from the remainder of the small intestine for analysis.
The entirety of the colon was harvested for analysis. The tissues were cut longitudinally
and placed in ice cold PBS + 1% penicillin/streptomycin (pen/strep) cocktail. Following
two washes in PBS + pen/strep, tissues were placed in a digestion solution containing 5%
heat-inactivated fetal bovine serum (FBS), 1% HEPES, 1% pen/strep, 0.5% gentamicin,
5mM EDTA, and 1mM dithiothreitol (D.T.T.) in Hank’s Balanced Salt Solution (HBSS)
at 37°C. Tissues were placed in a 37°C incubator and shaken on a rotator at 250rpm for
20 minutes. Tissues were vortexed to separate the epithelial cells from the tissue and
passed through a 100μm filter. Cells were counted on a hemocytometer to determine
epithelial cell purity (≥90%).

Intestinal epithelial cells were then processed for

downstream applications.
RNA Isolation and cDNA synthesis
RNA isolation was performed using a RNeasy Mini Kit (Qiagen, Valencia, CA)
as described by the manufacturer. Genomic DNA was removed by DNase digestion using
an RNase-free-DNase Set (Qiagen). Isolated RNA concentration was determined using a
NanoDrop 2000 spectrophotometer (Thermo Scientific, Bannockburn, IL). Only samples
with a 260/280 ratio of ≥2.0 were used for cDNA synthesis. cDNA synthesis was
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performed using a High Capacity cDNA Reverse Transcription Kit (Life Technologies,
Carlsbad, CA) and reactions were run on a Veriti 96-well Fast Thermocycler (Life
Technologies) per the manufacturer’s instructions.
Real-Time PCR
Expression of claudin-4, claudin-8, occludin, HSP25, HSP72, HSP90, and HSF1
mRNA levels were analyzed by qPCR using TaqMan primer probes and TaqMan Fast
Advanced Master Mix (Life Technologies). Target gene Ct cycle values were normalized
to housekeeping control GAPDH or -actin Ct values. Data were calculated using the
ΔΔCt method, and all groups were expressed relative to the sham group.
Cytokine quantification
IECs were isolated either from the distal 10cm of the small intestine or the colon,
allowed to incubate in 500uL of 1X cell lysis buffer (Cell Signaling Technology)
containing 1mM PMSF, 1X Protease inhibitor, 1X Phosphatase Inhibitor added (Cell
Signaling Technology). The homogenates were centrifuged at 10,000 RPM for 5min and
the supernatant was removed, aliquoted, and stored in -80°C for HSP25 (Enzo Life
Sciences), HSP72 (R&D), IL-18 (eBioscience), IL-6 (BD), KC (R&D), or MCP-1 (R&D)
ELISAs. Protein measurements of the same samples were done from Bio-rad protein
assay kit. Data were normalized as amount of cytokine/mg protein.
Immunofluorescence
Sections of the distal ileum (1cm) and proximal colon (1cm) were fixed in the
cryoprotective embedding medium, OCT, and frozen on dry ice. Tissue sections were
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prepared by the Loyola University Health and Sciences Division Processing Core.
Briefly, tissues were semi-permeabilized with 100% ice cold ethanol for 30 min, fixed in
100% ice cold acetone for 3 min, allowed to rehydrate in PBS for 1 min, and blocked
with Superblock (Scytek Laboratories) in humidity chamber for 5 min. Sections were
washed in appropriate amount of primary antibody to either claudin-4 (abcam) or
claudin-8 (Invitrogen) diluted at a concentration of 1:100 in 1%BSA in PBS, allowed to
incubate for 2 hours in humidity chamber, and washed 3X with PBS. Appropriate
amounts of secondary antibody conjugated to Alexa 488 diluted to a concentration of
1:1000 in 1% BSA in PBS were added and allowed to incubate in humidity chamber for 1
hour. Sections were washed in 3X PBS and phalliodin dye (Life Technologies) was
added to stain F-actin for 30 min in humidity chamber. Tissues were washed 3X PBS,
mounted with Prolong Gold antifade reagent with DAPI (Life Technologies), and sealed
after 24 hours. The sections were imaged using a Zeiss Axiovert 200m fluorescent
microscope and images were processed using Axiovision software.
FITC-dextran assay
One day after the aforementioned burn or sham injury procedure the mice were
gavaged with .4ml of 22mg/ml FITC-dextran in PBS.
After 3 hours blood was drawn, and the mice were sacrificed. Stomach content,
small intestine luminal content divided into three equal parts (with section #1 being
proximal and section #3 being distal), and large intestine feces were collected. The blood
was centrifuged at 8000rpm for 10min at 4°C, plasma isolated, and read
spectrophotometrically at 480nm excitation and 520nm emission wavelengths for
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intestinal permeability. Stomach content, small intestinal luminal contents #1, #2, and
#3, and large intestine feces were weighed, normalized by amount of PBS added,
sonicated (XL-2000 Misonix) until the solution was homogenous. Homogenates were
centrifuged at 8000rpm for 10min at 4°C, supernatants were collected, and read
spectrophotometrically at 480nm excitation and 520nm emission wavelengths for
intestinal transit.
Statistics
The data, wherever applicable, are presented as means + SEM and were analyzed
using analysis of variance (ANOVA) with Tukey’s post-hoc test or Student t test
(GraphPad Prism6). Unless otherwise noted, significance is reported as follows:
* p < 0.05, ** p < 0.01, *** p < 0.001

CHAPTER FOUR
RESULTS
Expression of Tight Junction Proteins Following Injury
As we had previously observed an increase in intestinal permeability and
subsequent bacterial translocation to extraintestinal sites following burn injury, we first
examined whether burn injury altered the expression of tight junction proteins. Tight
junction proteins uphold the physical intestinal barrier by joining two adjacent intestinal
epithelial cells allowing for the passive flux of nutrients from the lumen, but restricting
the large number of bacteria our GI tract harbors to the luminal space6,13,26,36,88. Any
change in expression of tight junction (TJ) proteins after burn injury could potentially
break this selective barrier allowing an increase in bacterial translocation7,82. Therefore,
we profiled the mRNA expression of several key TJ proteins, claudin-4, claudin-8, and
occludin, in both small and large IECS one and three days following either burn or sham
injury. In small intestine IECS, we observed a 54% decrease in claudin-4 expression and
49% decrease in claudin-8 expression relative to sham levels one day post burn on the
same day. The expression of these proteins was normalized to that of sham levels three
days after injury (Fig. 1). This is likely due to the extremely fast turnover rate of
intestinal epithelial cells, which is about 2-3 days. However, the downstream effect of
this early breakdown in tight junction complex integrity one day post burn injury could
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allow for the consequential translocation of bacteria out of the intestinal lumen ending
in one of the most common burn related complications: septic shock. There were no
significant changes in occludin expression in small intestine IECS one or three days post
burn injury (Fig. 1).
Next, we examined the same tight junction proteins in large intestine IECs one
and three days following burn injury. Similar to small intestine, IECs from large intestine
trend toward the same decreases in claudin-4 and claudin-8 but this was not found to be
significantly different from sham animals. Furthermore, this trend remained visible on
day three after burn (Fig. 2).
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SMALL INTESTINE IECs

Figure 1: Burn injury results in decreased expression of tight junction proteins in small
intestine IECs one day following injury. q-RTPCR Claudin-4, claudin-8, and occludin
mRNA expression relative to GAPDH. Values are mean ± SEM of 6-8 animals per group
expressed relative to sham. *, p<0.05 burn day one compared to sham by ANOVA and
Tukey post hoc test.
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LARGE INTESTINE IECs

Figure 2: Burn injury results in no significant changes in claudin4, claudin-8, or
occludin in large intestine IECs. q-RTPCR of Claudin-4, claudin-8, and occludin mRNA
expression relative to GAPDH. Values are mean ± SEM of 6-8 animals per group
expressed relative to sham. *, p<0.05 burn day one compared to sham by ANOVA and
Tukey post hoc test.
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Immunofluorescent Staining of Tight Junction Proteins
Additionally, we used immunofluorescence to visualize the distribution of the
tight junction proteins claudin-4 and claudin-8 in small intestine tissue sections. It is
imperative to understand how burn injury affects not only mRNA expression of tight
junction proteins, but also how tight junctional complexes at the protein level are altered
after burn injury. Using specific antibodies to claudin-4 or claudin-8, we observed
decreases in claudin-4 protein levels one day after burn injury compared to sham. No
significant changes in claudin-8 were observed in the small intestine.

25

Sham

Burn Day 1

Figure 3: Burn injury leads to a decrease in claudin-4 protein levels in small intestine
tissue one day after burn injury. Green color represents ALEXA 488 conjugated
secondary antibody to that of primary antibody towards claudin-4. Blue is a DAPI stain
for nuclei. The above image is 20X magnification.
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Sham

Burn Day 1

Figure 4: No significant difference in claudin-8 protein levels one day after burn injury.
Green color represents ALEXA 488 conjugated secondary antibody to that of primary
antibody towards claudin-8. Blue is a DAPI stain for nuclei. The above image is 20X
magnification.
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Burn Injury and Heat Shock Proteins (HSPs)

We next examined whether burn injury alters expression of HSPs in intestinal
epithelial cells (IECs). Burn related decreases in tight junction proteins, as we observed
in our studies, could result from alterations in HSPs. Other studies have implicated HSPs
as a source of stabilization of tight junction proteins in other barriers of the body,
including the blood brain barrier (BBB). The BBB is made up primarily of endothelial
cells, while the intestinal physical barrier is made of epithelial cells81. Yet, the way in
which both endothelial cells in the BBB and epithelial cells of intestinal tract structure
their tight junctional complexes is almost identical89. They are both made up of the class
of tight junction proteins, the claudins and occludins, and both allow for selective
permeability42,43,82,89. If HSPs are stabilizing the tight junction proteins of the intestinal
epithelial barrier in a manner similar to that of the BBB, then we would expect a decrease
in HSPs correlating with the decrease in TJ proteins we observe one day after burn injury
resulting in gut barrier breakdown. Therefore, we examined the HSPs 25, 72, and 90 in
both small and large IECs four hours, one, and three days after burn injury as they all
have been found to play a role in the maintenance of intestinal homeostasis17,18,24,31,83.
More specifically, HSP72 was found to be critical in the stabilization of tight junction
proteins in the BBB after injury24,83. At the mRNA level, we found significant decreases
in HSP25, 72, and 90 expression (25%, 85%, and 51% respectively) in IECs harvested
from the small intestine one day post burn injury compared to sham controls (Fig. 5).
Understanding how the mRNA message for HSPs can be disrupted after burn is
important, but it is critical to determine whether burn injury alters levels of the HSP
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protein response. Hence, at the protein level, burn injury resulted in a decrease of 85%
in HSP25 four hours after burn injury and significant decreases in HSP72 four (51%) and
three days (46%) in small intestine IECs compared to sham controls (Fig 6).
Upon examination of the HSPs 25, 72, and 90 in large intestine IECs four hours,
one day, and three days following burn injury, we observed a significant decrease, in all
three HSPs, 4 hours after injury of 44%, 79%, and 33% respectively compared to sham.
This significant decrease in HSP72 expression (81%) persisted to one day post burn
injury (Fig. 7). Protein levels of HSP25 mimicked mRNA expression with significant
decreases in HSP25 (71%) in large intestine IECs four hours after burn injury. Yet,
HSP72 levels post burn injury were significantly down in large intestine IECs on both
one (63%) and three days (46%) compared to sham controls (Fig. 8).
The suppression in HSPs in both small and large intestine post burn injury are
correlating with the significant decreases we observe in the tight junction proteins. This
gives evidence to our hypothesis that decreased expression of HSPs alters tight junction
proteins, which could drive the breakdown in gut barrier integrity after burn injury
potentiating the risk of sepsis and subsequent MODs in burn patients.
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SMALL INTESTINE IECs

Figure 5: Burn injury results in decreased expression of HSP25, 72, and 90 in small
intestine IECs one day after burn injury. q-RTPCR of HSP25, HSP72, and HSP90
mRNA expression relative to GAPDH. Values are mean ± SEM of 6-8 animals per group
expressed relative to sham. *, p<0.05 burn day one compared to sham by ANOVA and
Tukey post hoc test.
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Figure 6: Burn injury results in a suppressed HSP response in small intestine IECs in HSP25
four hours after injury and HSP72 four hours and three days after injury. IECs of the small
intestine were harvested and cells were lysed for protein extraction. ELISAs on HSP25 and
HSP72 were performed on the protein homogenate four hours, one day, or three days after
injury and expressed as pgHSP/mg protein. **, p<0.001, ***, p<0.0001 burn four hour or
one day compared to sham, ANOVA and Tukey multiple comparison tests. Values are mean
± SEM of 6-8 animals per group.
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LARGE INTESTINE IECs

Figure 7: Burn injury results in decreased expression of HSP25 four hours after injury,
HSP72 four hours and one day after injury, and HSP90 four hours after injury in large
intestine IECs. q-RTPCR of HSP25, HSP72, and HSP90 mRNA expression relative to
GAPDH. Values are mean ± SEM of 6-8 animals per group expressed relative to sham. *,
p<0.05, **, p<0.01, ***, p<0.001 all burn time points relative to sham by ANOVA and Tukey
post hoc test.

32

Figure 8: Burn injury results in a suppressed HSP response in large intestine IECs in HSP25
four hours after injury and HSP72 one and three days after injury. IECs of the large intestine
were harvested and cells were lysed for protein extraction. ELISAs on HSP25 and HSP72
were performed on the protein homogenate four hours, one day, or three days after injury and
expressed as pgHSP/mg protein. *, p<0.05, **, p<0.001, ***, p<0.0001 burn four hour or
one day compared to sham, ANOVA and Tukey multiple comparison tests. Values are mean
± SEM of 6-8 animals per group.
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Mesalamine Treatment
Mesalamine, or 5-aminosalysylic acid (5-ASA), is currently used as an antiinflammatory treatment for patients with Inflammatory Bowel Disease (IBD), a disease
characterized by severe elevations of pro-inflammatory cytokines in the gastrointestinal tract
causing severe discomfort in affected patients21,81. Most commonly, 5-ASA is used in the
treatment of ulcerative colitis or Crohn’s disease where it is theorized to work through an
inhibition of the major transcription factor of inflammatory mediators, NF-kB, or by
inhibiting the synthesis of TNF-21,32,81. However, another study looking at the mechanism
by which 5-ASA acts as an anti-inflammatory agent found that 5-ASA up-regulates the heat
shock protein HSP72 in rat intestinal epithelial cells81. Induction of HSP72 would allow for
an alleviation of inflammation and stress to the cell via proper folding of naïve proteins
needed to combat increased inflammation and proper re-folding of damaged proteins as a
result of cell stress24.
We attempted to induce HSPs in our murine model of burn injury with the
hypothesis that if HSPs stabilize TJ proteins, up-regulating HSPs after burn injury could
potentially restore the decrease in TJ proteins we observe and bring back normal barrier
function. To perform this experiment, mice were divided into four groups: sham plus saline,
sham plus 5-ASA, burn plus saline, and burn plus 5-ASA. Immediately after burn injury,
mice were given an intraperitoneal (i.p.) injection of 100mg/kg of 5-ASA dissolved in 1 mL
of saline used for the normal resuscitation. The mice were then sacrificed one day after burn
injury, as it is the time point where we see the most significant changes. We found that mice
treated with 100mg/kg 5-ASA at time of resuscitation, did not up-regulate HSP25 or 72
in either small or large intestine IECs as seen by mRNA expression in Figure 9.
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Examination of HSP72 at the protein level confirmed that 5-ASA did not increase the
HSP72 response after burn injury (Fig. 10). To further elucidate whether 5-ASA could
upregulate HSPs in response to burn injury, we looked further upstream at the master
transcriptional regulator of HSPs, HSF118. Quantification of mRNA expression of HSF1
after treatment with 5-ASA in the context of burn injury showed no significant changes in
either small or large intestine IECs compared to the burn injury alone group (Fig. 11a and
11b). It is of interest to note, that burn injury alone does produce a significant decrease in
HSF1 in both small and large intestine IECs one day after burn compared to sham
controls, which gives evidence to our observations of decreased levels of HSPs following
burn injury.
However, 5-ASA treatment did significantly restore claudin-4 and trends toward
restoration of occludin expression in small intestine IECs one day after burn injury (Fig.
12). No changes in claudin-8 expression were observed in small intestine IECs following
5-ASA treatment after burn injury as seen in Figure 12. There was no restoration of the
large intestine IEC tight junction proteins, claudin-4, claudin-8, or occludin, one day after
burn injury with 5-ASA treatment (Fig. 13).
Burn injury is associated with high levels of inflammation in the gastrointestinal
tract, which can potentiate increases in intestinal permeability82,90. We broadened our
analysis of 5-ASA treatment to determine whether 5-ASA could be deemed beneficial in
reducing the high levels of pro-inflammatory cytokines and chemokines. We, and others,
have previously seen elevated post burn injury, such as IL-18, IL-6, KC, and MCP17,82,91. 5-ASA significantly reduced the small intestine IEC pro-inflammatory cytokines
IL-18 (62% increase one day after burn and back to sham levels with 5-ASA) and IL-6
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(34% increase back to sham levels one day post burn) in IECs after burn injury (Fig.
14). No significant changes were observed in the pro-inflammatory chemokine MCP-1
in small intestine IECs with 5-ASA treatment (Fig. 14).
In large intestine IECs there was a trend towards a reduction in IL-6 and the proinflammatory cytokine KC with 5-ASA treatment one day following burn injury.
Interestingly, there was a significant decrease (63%) in the pro-inflammatory chemokine
MCP-1 following 5-ASA treatment one day after burn injury in large intestine IECs (Fig.
15).
Increases in intestinal inflammation have been shown to potentiate increases in
intestinal permeability82, both of which have been theorized to inhibit intestinal
peristalsis11,92. The inability to effectively move luminal content down the GI tract could
dramatically change the luminal microenvironment creating more favorable environments for
opportunistic pathogens11,36,42,45,92,93. Our lab has previously reported drastic alterations in
microbial communities of the intestinal tract after burn injury94 (submitted manuscript). This
compounded with stalled intestinal peristalsis and increases in intestinal permeability could
give evidence to our reports of bacterial translocation to extraintestinal sites resulting in some
of the most common burn related complications of sepsis and MODs95. Therefore, it is
critical to determine whether burn injury not only results in increased intestinal permeability,
but also whether burn inhibits intestinal peristalsis. Hence, we performed a FITC-dextran
permeability and transit assay. Mice were gavaged with FITC-dextran one day after burn
injury. Three hours later plasma, stomach content, small intestine luminal content divided
into three equal sections, and large intestine feces were collected and analyzed for the
presence of FITC spectrophotometrically.
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We have previously reported increases in intestinal permeability one day following
burn injury using the aforementioned FITC-dextran assay94 (submitted manuscript). After
applying the FITC-dextran assay to assess intestinal transit, we found that burn injury
significantly inhibits normal intestinal transit in burn injured animals as evidenced by an
accumulation of FITC-dextran in the stomach content and small intestine #1 (Fig. 16). To
our knowledge, however, there has been no attempt to reduce intestinal permeability and
restore intestinal peristalsis following burn injury via treatment with 5-ASA. Therefore, we
performed the FITC-dextran assay with the addition of 5-ASA treatment to determine
whether 5-ASA following burn injury would decrease intestinal permeability and restore
intestinal peristalsis.
As we’ve seen previously, the concentration of FITC-dextran in the plasma was
significantly increased in burn injury alone relative to sham control giving evidence to
increased gut leakiness post burn injury. With 5-ASA treatment following burn, the increase
in intestinal permeability was completely restored to that of sham levels as there is no
statistically significant difference in FITC-dextran concentrations in the plasma between
sham controls and 5-ASA treated burn animals (Fig. 17). Additionally, treatment with 5-ASA
following burn injury helps restore normal functioning intestinal peristalsis. This can be seen
in Figure 18 with sham animals having the largest concentration of FITC-dextran transiting
all the way to the colon. On the other hand, the FITC-dextran transit is halted in burned
animals evidenced by zero to very little FITC-dextran in the colon with the vast majority
residing in the stomach and small intestinal content #1. Treatment with 5-ASA post burn
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allows for more efficient transit of FITC-dextran as more FITC-dextran can be detected in
large feces with treatment (Fig. 18). It is not, however, back to sham control levels.
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SMALL INTESTINE IECs

LARGE INTESTINE IECs

Figure 9: 5-ASA treatment after burn injury does not significantly induce mRNA
expression of HSP25 or HSP72 following injury. q-RTPCR of HSP25 and HSP72 mRNA
expression in large and small intestine IECs relative to -actin. Values are mean ± SEM
of 6-8 animals per group expressed relative to sham. *, p<0.05, **, p<0.01, ***, p<0.001,
****, p,0.0001 all groups relative to sham by ANOVA and Tukey post hoc test.
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SMALL INTESTINE IECs

LARGE INTESTINE IECs

Figure 10: 5-ASA treatment after burn injury does not significantly induce protein levels
of HSP72 in either small or large intestine IECs. IECs of the small and large intestine were
harvested and cells were lysed for protein extraction. ELISA on HSP72 was performed on
the protein homogenate one day after injury and expressed as pg HSP/mg protein. *, p<0.05,
**, p<0.001, ****, p<0.0001 all groups compared to sham, ANOVA and Tukey multiple
comparison tests. Values are mean ± SEM of 6-8 animals per group.
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SMALL INTESTINE IECs

LARGE INTESTINE IECs

Figure 11: 5-ASA treatment after burn injury does not significantly induce mRNA
expression of HSF1 in either small or large intestine IECs. q-RTPCR of HSF1 mRNA
expression in large and small intestine IECs relative to -actin. Values are mean ± SEM
of 6-8 animals per group expressed relative to sham. *, p<0.001, **, p<0.0001 all groups
relative to sham by ANOVA and Tukey post hoc test.
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SMALL INTESTINE IECs

Figure 12: Treatment with 5-ASA at time of burn injury significantly restores small intestine
IEC claudin-4 expression to that of sham levels one day after injury, while a trend toward
restoration exists of occludin expression in small intestine IECs one day post injury. qRTPCR of claudin-4, claudin-8, and occludin mRNA expression relative to -actin.
Values are mean ± SEM of 6-8 animals per group expressed relative to sham. *, p<0.05, **,
p<0.01, ***, p<0.001 burn day one compared to sham by ANOVA and Tukey post hoc test.
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LARGE INTESTINE IECs

Figure 13: Treatment with 5-ASA at time of burn injury does not affect expression of
claudin4, claudin-8, or occludin in large intestine IECs after injury. q-RTPCR of claudin-4,
claudin-8, and occludin mRNA expression relative to -actin. Values are mean ± SEM of
6-8 animals per group expressed relative to sham. *, p<0.05, **, p<0.01, ****, p<0.001 burn
day one compared to sham by ANOVA and Tukey post hoc test.
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SMALL INTESTINE IECs

Figure 14: Treatment with 5-ASA after burn injury significantly reduces the observed
increase in the pro-inflammatory cytokines IL-18 and IL-6 back to that of sham levels one
day after injury in small intestine IECs, with a trend toward reduction in the proinflammatory chemokine, KC, one day after injury. IECs of the small intestine were
harvested and cells were lysed for protein extraction. ELISAs on IL-18, IL-6, KC, and MCP1 were performed on the protein homogenate one day after injury and expressed as pg/mg
protein. *, p<0.05, **, p<0.001, all groups compared to sham, ANOVA and Tukey multiple
comparison tests. Values are mean ± SEM of 6-8 animals per group.
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LARGE INTESTINE IECs

Figure 15: Treatment with 5-ASA after burn injury significantly reduced the proinflammatory chemokine, MCP-1, back to that of sham levels in large intestine IECs one
day after injury. 5-ASA treatment produced a trend towards a reduction in the proinflammatory cytokine/chemokines of IL-6 and KC one day after injury in large intestine
IECs. IECs of the large intestine were harvested and cells were lysed for protein extraction.
ELISAs on IL-6, KC, and MCP-1 were performed on the protein homogenate one day after
injury and expressed as pg/mg protein. *, p<0.05, all groups compared to sham, ANOVA and
Tukey multiple comparison tests. Values are mean ± SEM of 6-8 animals per group.
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INTESTINAL TRANSIT

Figure 16: Decreases in intestinal transit one day after burn injury. . Mice were gavaged
with FITC-dextran one day after burn or sham injury. Three hours after FITC-dextran
gavage stomach content, small intestine luminal content divided into three equal lengths (#1
being proximal to stomach and #3 being distal), and large intestine feces were collected and
visualized spectrophotometrically for presence of FITC-dextran. Values are mean ± SEM of
6-8 animals per group.
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INTESTINAL PERMEABILITY AFTER 5-ASA

Figure 17: Treatment with 5-ASA following burn injury significantly reduces intestinal
permeability and restores intestinal peristalsis to that of sham levels one day after injury.
Mice were gavaged with one day after either burn or sham injury. Three hours later FITCdextran was measured in plasma spectrophotometrically. Values are mean ± SEM of 4-6
animals per group. ***, p<0.0001 burn saline compared to sham control , ANOVA and Tukey
multiple comparison tests.
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INTESTINAL TRANSIT AFTER 5-ASA

Figure 18: 5-ASA treatment partially restores normal intestinal transit one day after burn
injury. Mice were gavaged with FITC-dextran one day after burn or sham injury. Three
hours after FITC-dextran gavage stomach content, small intestine luminal content divided
into three equal lengths (#1 being proximal to stomach and #3 being distal), and large
intestine feces were collected and visualized spectrophotometrically for presence of FITCdextran. Values are mean ± SEM of 4-6 animals per group.

CHAPTER FIVE
SUMMARY AND DISSCUSSION

Sepsis and Multiple Organ Dysfunction syndrome remain the leading causes of
post-burn morbidity and mortality 3-5,29. Understanding the contributing factors and
mechanisms behind the dysregulated immune response after burn trauma, which
significantly predisposes patient’s risk for secondary infections, is necessary for
development of novel therapeutic intervention. As the gastrointestinal tract harbors
trillions of resident bacteria, any breakdown in the intestinal epithelial barrier
sequestering those bacteria to the luminal space can result in bacterial translocation to
extraintestinal sites giving rise to patient’s risk of sepsis 10,88. IECs are sealed together
via tight junctional complexes 43. HSPs are known stabilizers of TJ proteins 24,89.
Therefore, it is critical to not only understand the role of TJ proteins in gut barrier
integrity following burn, but also the role of HSPs. We hypothesized that decreased
expression in the HSP response in IECs following burn injury potentiates decreases in TJ
protein expression increasing intestinal permeability. The studies performed herein
identify post burn changes in TJ proteins in IECs correlating with suppression of the HSP
response, which suggests a potential role for HSPs in the maintenance of gut barrier
integrity. This breakdown in HSPs and TJ proteins in IECs following burn injury could
allow for bacterial translocation out of the lumen and into circulation, which could drive
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the systemic inflammatory response and subsequent septicemia common in burn
related trauma.
Under normal homeostatic conditions, IECs maintain the physical barrier of the
intestinal tract by joining adjacent epithelial cells via formation of tight junctional
complexes. This interaction is imperative to the integrity of a healthy gut, and any
perturbation in tight junction protein expression of IECs could increase gut leakiness and
bacterial translocation 7,15,16,43,82,95,96. Therefore, we measured the expression of the tight
junction proteins claudin-4, claudin-8, and occludin following burn injury. Using qRTPCR we observed decreases in claudin-4 and claudin-8 expression one day after burn
injury in small intestine IECs and a trend towards the same decreases on day one in large
intestine IECs in both claudin-4 and claudin-8. Upon immunofluorescent staining of
claudin-4 and claudin-8 in small intestinal tissue, we saw decreases in claudin-4 levels
one day after injury. These alterations in TJ protein expression give evidence to our
previously observed increases in intestinal permeability and bacterial translocation to
extraintestinal sites, such as the MLNs, one day after burn injury 94. As tight junctional
complexes are comprised of many tight junction proteins such as claudin-1, claudin-2,
claudin-3, zonal-occludin-3 and many others, expanding our analysis to include these
other tight junction proteins would allow for better understanding of the breakdown in
structure of tight junctional complexes following burn trauma.

Understanding the

contributing factors leading to TJ protein alterations after burn injury would allow for the
intervention of new therapies directed at their specific upregulation or their upregulation
via secondary targets.
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We hypothesized that decreases in TJ protein levels following burn trauma was
the result of a suppressed HSP response. At the cellular level, the host responds to acute
environmental stress, such as disruptions in gut homeostasis after burn injury, by
inducing the heat shock protein response. As cyto-protective proteins, the presence of
HSPs would allow for alleviation of aforementioned stress by correctly re-folding
denatured proteins as a consequence of stress and also aiding in the folding of naïve
proteins needed to combat cellular stress 17,18,46,49,54,55,61,68. Since it is not known how the
HSP response is affected after burn injury, we measured the expression of the three most
studied HSPs, HSP25, HSP72, and HSP90, in small and large intestine IECs four hours,
one day, and three days post burn injury 47,56,57. We found that burn injury decreased
mRNA expression of HSP25, 72, and 90 in small intestine IECs one day after injury. In
large intestine IECs, burn decreases expression of HSP25 four hours after injury, HSP72
four hours and one day after injury, and HSP90 four hours after injury. It is imperative to
understand how burn injuries affect not only mRNA expression of HSPs, but also how
HSPs at the protein level are altered after burn injury. Hence, at the proteins level, we
found a suppressed HSP response in small intestine IECs in HSP25 four hours after injury
and HSP72 four hours and three days after injury. In large intestine IECs, burn injury
resulted in decreases in HSP25 four hours after injury and HSP72 one and three days after
injury.
Although the exact mechanisms behind the cyto-protective functions of HSPs are yet
to be fully understood, their expression has been linked to protection in various diseases such
as ALS, ischemic heart disease, and IBD

14,50,54,57,61,68,70,74

. Transgenic mice have been

created to overexpress the human isoform of HSP72, HSP70, and it would be interesting to
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assess whether HSP70 overexpressing mice allow for protection from burn induced
complications of intestinal permeability, inflammation, and bacterial translocation compared
to wild type mice 57,74.
Mesalamine (5-ASA) has been shown to significantly reduce symptoms of intestinal
inflammation in patients with two forms of IBD: Crohn’s disease and ulcerative colitis
20,21,27,77,78

. 5-ASA has been shown to induce HSP72 in vitro in rat intestinal epithelial cells

in response to cellular stress, providing a mechanism of protection to rat IECs 81. As the
intestinal inflammation and subsequent damage to intestinal epithelial cells in IBD mimics
what we observe in burn intestines, we attempted to induce the HSP response in vivo with 5ASA after burn injury. Measurement of HSP25, HSP72, and HSP90 after 5-ASA treatment
yielded no significant induction in any of the three HSPs in both small and large intestine
IECs. However, 5-ASA treatment did significantly restore claudin-4 and trends toward
restoration of occludin expression in small intestine IECs one day after burn injury. As
burn injury results in high levels of inflammation in the gastrointestinal tract, which can
potentiate increases in intestinal permeability, we measured levels of IL-18, IL-6, KC,
and MCP-1 in small and large IECs one day after burn with 5-ASA treatment

82,90

.

We’ve previously reported increase in all four pro-inflammatory cytokines/chemokines in
intestinal tissues, and found that 5-ASA significantly reduced the small intestine IEC proinflammatory cytokines IL-18 and IL-6 in IECs after burn injury 7,82,91. In large intestine
IECs there was a trend towards a reduction in IL-6 and the pro-inflammatory cytokine
KC with 5-ASA treatment one day following burn injury. Interestingly, a drastic decrease
in the pro-inflammatory chemokine MCP-1 was observed following 5-ASA treatment one
day after burn injury in large intestine IECs.
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Intestinal inflammation can significantly increase intestinal permeability, both of
which can halt normal intestinal peristalsis

11,82,94

. Without the ability to move luminal

content down the GI tract, drastic changes in the microenvironment of the gut can ensue,
producing environments more suited to opportunistic pathogens 11,16,36,44,92,94,95.

We have

previously reported severe dysbiosis of the intestinal tract after burn injury, and compounded
with inhibition of intestinal peristalsis and increases in intestinal permeability, would give rise
to our reports of bacterial translocation to extraintestinal sites 15,94,95. Treatment with 5-ASA
reduced intestinal permeability to that of sham levels and partially restored the intestinal
peristalsis we observe one day following burn injury.
5-ASA treatment after burn injury has its limitations as the highest dosage able to be
dissolved in normal saline is 100mg/kg. Future studies will be critical to determine dosages
and delivery systems for optimal efficacy.
Treatment with 5-ASA does not act as an agonist of HSPs after burn. Yet, it could
potentially be used as treatment to decrease intestinal permeability by restoring tight
junctional complexes and decreasing the inflammation associated with burn injury.

APPENDIX
SPECIFIC METHODS

[53]

[54]
Mouse Model of Thermal Injury
Adult C57BL/6 mall mice (7-8 weeks old, 22-25g body weight, Charles River
Laboratories) were chosen randomly for all experiments. Animals received sham or burn
injury yielding two groups. For the 5-ASA treatment, animals were divided into four groups
sham + saline , sham + 5-ASA, burn + saline, and burn + 5-ASA. The mice were
anesthetized with a intraperitoneal injection of ketamine hydrochloride/ xylazine cocktail
(~80mg/kg and 1.2 mg/kg, respectively). The dorsal surface was shaved and the mice were
transferred to a template calculated to expose ~20% TBSA as calculated by the Meeh
formula, A=kW2/3, given k=10, and weight in grams86. The mice were submerged in a water
bath set to 85°C for 7-9 seconds to emulate burn injury or a water bath set to 37°C to emulate
sham injury. Following the burn the mice were resuscitated with an intraperitoneal injection
of 1ml of saline. For the 5-ASA treatment, 5-ASA treatment groups received 100mg/kg 5ASA (Santa Cruz) dissolved in normal saline. Animals were allowed food and water ad
libitum. Mice were sacrificed and organs or tissue were collected four hours, one, or three
days after injury.

[55]
qPCR
For quantification of gene expression, RT-qPCR
RNA Purification
1. RNA was purified using RNeasy mini kit by Qiagen.
2. Tissue stored in RNA later was excised, 20 mg, and homogenized in lysis buffer
with a rotor fixed tissue shredder for 30 seconds.
3. Sample was added to Qiagen spin columns and DNA was digested using the
Qiagen DNase digest to remove any contaminating genomic DNA following the
manufacturers.
4. Inhibitors were washed off the columns using buffers AW1 and AW2
5. Sample was eluted using 50.l of TE

Reverse Transcription
1. Reverse transcription reaction was performed using Applied Biosystems high capacity
cDNA reverse transcription kit and following the manufacturers instructions.
2. Each sample was diluted to 33.75ng/.l and 10.l of each sample was added to a 96 well plate
3. 10.l of RT master mix was added to each sample which contained, the reverse transcription
enzyme, dNTPs, random primers, and H20 at a 1X concentration.
4. The reaction was run using Applied Biosystems Veriti thermal cycler using the
manufacturers recommendations.
5. The cDNA was diluted down to 30/8 ng/.l for qPCR

qPCR
1. The qPCR master mix was created using 10.l/rxn TaqMan Fast Advanced qPCR
supermix, 1.l/rxn TaqMan primer and probe (FAM), and 1.l/rxn TaqMan GAPDH or actin endogenous control (VIC).
2. 12.l was pipetted into each well of a 96 well plate
3. 8.l of cDNA sample at 30/8 .l was pipetted into the corresponding well
4. The reaction was run using the FAST Applied Biosystems protocol on Step One Plus
qPCR machine, Applied Biosystems

[56]
ELISA
Tissue Homogenization:
Supplies:
•Lysis buffer, Cell Signaling Technologies
•Protease Inhibitor Cocktail
• PMSF
•Homogenizer Qiagen
• Sonicator

Procedure:
1. Prepare lysis buffer: Cell signaling technologies, protease inhibitor cocktail, phosphatase
inhibitor, and PMSF to manufacturers instructions
2. Add 500.l lysis buffer per sample (small intestine IECs or entire large intestine IECs from
cecum)
3. Keep samples on ice 45 min.
4. Centrifuge for 5 min at 10000rpm at 4°C.
5. Collect and aliquot.
6. Store homogenates at -80°C.

ELISA Supplies:
• HSP25 ELISA kit (Enzo Life Sciences)
• HSP72 ELISA kit (R&D)
• IL-18 ELISA kit (eBioscience)
• IL-6 ELISA kit (BD)
• KC ELISA kit (R&D)
• MCP-1 ELISA kit (R&D)
Procedure:
1. Samples were diluted depending on the specific ELISA kit used so that the unknowns were
within the standard curve
2. ELISA procedure was performed exactly as according to the manufacturer’s protocol, and
suggested antibody dilutions
3. Read plate with a spectrophotometer at wavelengths suggested by manufacturer.

[57]
Immunofluorescence
Supplies
 Humidity Chamber
 Pap Pen
 100% ice cold acetone
 100% ice cold ethanol
 1X PBS
 1% BSA in 1X PBS
 Primary antibody to protein of interest
 Secondary antibody conjugated to fluorophore
 Prolong Gold antifade reagent with DAPI
Procedure
1. Mark area with pap pen
2. Immerse slides in 100% ice cold ethanol for 30 min in freezer.
3. Remove slide from ethanol and immerse in 100% ice cold acetone for 3 min in freezer.
4. Remove from acetone and allow to air dry for 3 min
5. Immerse in 1X PBS for 1 min
6. Put slide in humidity chamber. Add 200L Superblock over tissue area. Incubate for 5
min.
7. Rinse 3X in PBS for 2 min
8. Add appropriate amount of primary antibody ~200L in 1% BSA in PBS over tissue area
in humidity chamber. Incubate for 2 hours.
9. Rinse 3X in PBS for 2 min.
10. Turn lights off.
11. Add appropriate amount of secondary antibody ~200L in 1% BSA in PBS over tissue
area in humidity chamber. Incubate for 1 hour.
12. Rinse 3X in PBS for 2 min.
13. Add ~200L phalloidin dye to tissue area in humidity chamber. Incubate for 30 min.
14. Rinse 3X in PBS for 2 min.
15. Dry slides.
16. Mount with Prolong Gold antifade reagent with DAPI.
17. Allow to dry overnight.
18. Image with Zeiss Axiovert 200m fluorescent microscope

[58]
FITC-dextran Permeability and Transit Assay
1. On the day of sacrifice, gavage mice with .4ml of 22mg/ml FITC-dextran (SigmaAldrich) in PBS.
2. After 3 hours draw blood and sacrifice the mice.
3. Collect:
-stomach content
-small intestine luminal content divided into 3 equal parts: #1, #2, #3
-#1 being proximal to stomach and #3 being most distal
4. The blood was centrifuged for 8000rpm for 5min at 4°C, plasma isolated.
5. Each animals stomach and luminal contents from each section were weighed and
normalized to 5X PBS addition.
6. Sonicate for 30 seconds using XL-2000 Misonix.
7. Centrifuge samples for 10 min at 8000rpm at 4°C.
8. Remove supernatant.
9. Standards of FITC-dextran was prepared using 2 fold dilutions of pure FITCdextran in PBS, the high standard being 3 mg/ml for luminal content and 100g/ml for
plasma.
10. Equal volumes of standard, plasma, and luminal content were pipetted into the
corresponding well, 96 well plate.
11. The plate was read spectrophotometrically at 480nm excitation and 520nm.
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